Published in Hepatitis Weekly, September 16th, 1996
George Marinos and colleagues further noted that these variants always coexist with the wild-type hepatitis B virus (HBV), and that the presence of core gene deletion variants does not confer resistance to interferon-alpha (IFN-(alpha)) treatment.
Nucleotide sequence analysis of the HBV genome has shown considerable variation and heterogeneity in the virus population among different patients with chronic HBV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-09-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.